Month: June 2020

This is not your grandmother’s IRA.
In Marc’s latest State of the Market video – which aired on Wealthy Retirement‘s YouTube channel yesterday – he addressed a common misconception that costs too many seniors in retirement…
That diligent savers who want to secure wealth in their golden years don’t have the time to waste on bond investing.
In fact, nothing could be further from the truth.
True, bonds are not the James Dean of the market. They won’t often get your adrenaline pumping like fast-paced options trading…
But they won’t cause inexperienced traders the same gut-wrenching losses, either.
And if you ask readers of Marc’s Oxford …read more […]

It is very likely that Gold has rallied to these current levels as a “global hedge against risk” and that Silver has been overlooked as a secondary asset. …read more […]

Why the Mercedes-Benz AMG G 63 is the ultimate SUV for self-isolation. …read more […]

Market forces rained on the parade of Heat Biologics, Inc. (NASDAQ:HTBX) shareholders today, when the analysts… …read more […]

(Bloomberg) — The Trump administration, following a backlash, said it would release details about companies that received loans of $150,000 or more from a coronavirus relief program for small businesses.Treasury Secretary Steven Mnuchin said last week the firms that got billions of dollars in taxpayer-funded aid wouldn’t be disclosed, sparking fury from Democrats and others. In a joint statement on Friday night, the Treasury Department and the Small Business Administration said the company names, addresses, demographic data and other information would be disclosed in five ranges — starting with $150,000 to $350,000, and going up to between $5 million and …read more […]

The market’s helter-skelter tone is largely reflective of the competing impulses of a nationwide rise in COVID-19 diagnoses and expectations for an economic revival. …read more […]

Luxury RV’s are seeing unprecedented demand. …read more […]

The Forma Therapeutics IPO launched on the Nasdaq market. It hit less than a month after the company filed with the SEC. As biotech companies successfully go public, Forma Therapeutics stock could be the next hit.
But is it a good investment opportunity? Here’s what we know…
Forma Therapeutics IPO: The Business

Forma Therapeutics is a biopharmaceutical company. It aims to develop and commercialize novel therapeutics to help patients with rare hematologic diseases and cancers. The company’s focus is sickle cell disease (SCD) and prostate cancer.
In 2019, Forma reorganized, filing from a limited liability company to a corporation. The company also named Frank …read more […]

One thing we could say about the analysts on Carnival Corporation & Plc (NYSE:CCL) – they aren’t optimistic, having… …read more […]

Some promising ventures may succumb to unfortunate circumstances, but the economic crisis also reveals which early-stage companies can draw on the effective leadership and sustainable business model necessary to weather a downturn, says Stephanie Mehta, the editor-in-chief of business publication Fast Company. …read more […]

If you think the former Vice President will win the presidential election, then it’s probably a good idea to understand what a Biden presidency means for the economy, markets and business. …read more […]

German payments firm Wirecard said late on Friday it had hired U.S. investment bank Houlihan Lokey to develop a new financing strategy as Moody’s slashed the company’s rating to junk following the disappearance of 1.9 billion euros. The scandal-hit company is desperately seeking to reassure investors after its search for the missing cash hit a dead end in the Philippines, prompting ratings agencies to react. The company’s CEO quit on Friday. …read more […]

(Bloomberg) — Just a month ago, the chief executive officer of Wirecard AG boasted on Twitter that the future would still be bright for the digital payments company when “all the noise and dust settles.”At the time, Markus Braun was a paper billionaire. But over the course of a couple of days, the fintech veteran has been forced to step-down as CEO and seen the value of his stake dwindle after a two-day stock rout.Braun’s position at the German payments company became untenable after revelations on Thursday that about 1.9 billion euros ($2.1 billion) — two-thirds of 2019 revenue and …read more […]

For years now, Aurora Cannabis (ACB) and Canopy Growth (CGC) have traded in near lockstep based on the global growth potential of cannabis. The latest quarterly results set Aurora Cannabis a step ahead of their prime competitor in Canada.Aurora Cannabis reported an exceptional turnaround quarter for March, but the stock has taken a hit following the weak Canopy Growth results at the end of May. Oddly, Aurora Cannabis now appears better positioned to thrive having already had to tighten their financial purse strings due to cash concerns.Value Brand ShiftCanopy Growth called out a prime reason for their failure to hit …read more […]

AMC is reversing course on its face mask policy following mounting pressure from health officials and patrons. …read more […]